LONDON (Reuters) - An experimental drug for severe sepsis from AstraZeneca and BTG failed to help patients in a mid-stage clinical trial and its development will now be halted, BTG said on Wednesday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment